NEW YORK—Parachute Health, a digital order management platform for home medical equipment (HME), unveiled its latest State of DME ePrescribing report with data through Jan. 1, 2025, showcasing significant growth in digital ordering, deeper engagement from health plans and advancements in AI-powered automation. The report provides a guide on:
- Adoption of durable medical equipment (DME) ePrescribing across care settings and categories
- Platform data and key trends
- Opportunities for clinicians, HME providers, health plans, hospital systems, homecare organizations and other health care professionals in 2025 and beyond
Among the most anticipated announcements, Parachute Health launched AI Intake, a solution for HME providers to efficiently process fax orders and ePrescribed orders together in one platform. The platform now functions as a comprehensive end-to-end order management platform—giving HME providers a competitive edge in efficiency, patient care and referral service.
Industry-Wide Growth & New Health Plan Partnerships
Parachute Health’s footprint across the HME industry has grown significantly since its last State of DME ePrescribing report, with a significant increase in platform adoption including 50,000 new signing doctors.
Key milestones in 2024 include:
- AI Intake: Enables HME providers to use Parachute on faxed and ePrescribed orders, further cutting down processing times and reducing administrative burdens.
- Integrated Prior Authorization: Parachute is now streamlining the prior authorization process to reduce friction at the point of care and improve patient outcomes.
- Breakthroughs in Patient Engagement: Allows HME providers to easily communicate with patients, provide order status updates, and secure necessary documentation.
Link to Report: parachutehealth.com/dme-report-2024